Bone loss in survival motor neuron (Smn-/- SMN2) genetic mouse model of spinal muscular atrophy

被引:58
|
作者
Shanmugarajan, Srinivasan [1 ]
Tsuruga, Eichi [1 ]
Swoboda, Kathryn J. [3 ]
Maria, Bernard L. [1 ]
Ries, William L. [2 ]
Reddy, Sakamuri V. [1 ]
机构
[1] Charles P Darby Childrens Res Inst, Charleston, SC 29425 USA
[2] Med Univ S Carolina, Coll Dent Med, Charleston, SC 29425 USA
[3] Univ Utah, Sch Med, Dept Pediat, Div Neurol, Salt Lake City, UT USA
基金
美国国家卫生研究院;
关键词
spinal muscular atrophy; osteoclast; RANK ligand; survival motor neuron; mouse model; OSTEOCLAST FORMATION; BINDING-PROTEIN; IDENTIFICATION; MECHANISMS; FRACTURES; MICE; INTERACTS; PRODUCT; VARIANT;
D O I
10.1002/path.2566
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Spinal muscular atrophy (SMA) is characterized by degenerating lower motor neurons and an increased incidence of congenital bone fractures. Survival motor neuron (SMN) levels are significantly reduced due to deletions/mutations in the telomeric SMN1 gene in these patients. We utilized the Smn(-/-) SMN2 mouse model of SMA to determine the functional role for SMN in bone remodelling. mu CT analysis of lumber vertebrae, tibia and femur bones from SMA mice revealed an osteoporotic bone phenotype. Histological analysis demonstrated a thin porous cortex of cortical bone and thin trabeculae at the proximal end of the growth plate in the vertebrae of SMA mice compared to wild-type mice. Histochemical staining of the vertebrae showed the presence of abundant activated osteoclasts on the sparse trabeculae and on the endosteal surface of the thin cortex in SMA mice. Histomorphometric analysis of vertebrae from SMA mice showed an increased number of osteoclasts. Serum TRAcP5b and urinary NTx levels were elevated, consistent with increased bone resorption in these mice. SMA mice showed a significant decrease in the levels of osteoblast differentiation markers, osteocalcin, osteopontin and osterix mRNA expression; however, there were no change in the levels of alkaline phosphatase expression compared to WT mice. SMA mouse bone marrow cultures revealed an increased rate of osteoclast formation (54%) and bone resorption capacity (46%) compared to WT mice. Pre-osteoclast cells from SMA mice showed constitutive up-regulation of RANK receptor signalling molecules critical for osteoclast differentiation. Our results implicate SMN function in bone remodelling and skeletal pathogenesis in SMA. Understanding basic mechanisms of SMN action in bone remodelling may uncover new therapeutic targets for preventing bone loss/fracture risk in SMA. Copyright (C) 2009 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
引用
收藏
页码:52 / 60
页数:9
相关论文
共 50 条
  • [41] Universal fluorescent multiplex PCR and capillary electrophoresis for evaluation of gene conversion between SMN1 and SMN2 in spinal muscular atrophy
    Wang, Chun-Chi
    Jong, Yuh-Jyh
    Chang, Jan-Gowth
    Chen, Yen-Ling
    Wu, Shou-Mei
    ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2010, 397 (06) : 2375 - 2383
  • [42] Analysis of Deletions in SMN1, SMN2, and NAIPGenes in Spinal Muscular Atrophy Patients from the Northwestern Region of Russia
    A. S. Glotov
    A. V. Kiselev
    T. E. Ivaschenko
    V. S. Baranov
    Russian Journal of Genetics, 2001, 37 : 968 - 971
  • [43] Genetic and expression studies of SMN2 gene in Russian patients with spinal muscular atrophy type II and III
    Zheleznyakova, Galina Yu
    Kiselev, Anton V.
    Vakharlovsky, Viktor G.
    Rask-Andersen, Mathias
    Chavan, Rohit
    Egorova, Anna A.
    Schioth, Helgi B.
    Baranov, Vladislav S.
    BMC MEDICAL GENETICS, 2011, 12
  • [44] No significant sex differences in incidence or phenotype for the SMN A7 mouse model of spinal muscular atrophy
    Cottam, Nicholas C.
    Harrington, Melissa A.
    Schork, Pamela M.
    Sun, Jianli
    NEUROMUSCULAR DISORDERS, 2024, 37 : 13 - 22
  • [45] Systemic Delivery of scAAV9 Expressing SMN Prolongs Survival in a Model of Spinal Muscular Atrophy
    Valori, Chiara F.
    Ning, Ke
    Wyles, Matthew
    Mead, Richard J.
    Grierson, Andrew J.
    Shaw, Pamela J.
    Azzouz, Mimoun
    SCIENCE TRANSLATIONAL MEDICINE, 2010, 2 (35)
  • [46] High Concentration or Combined Treatment of Antisense Oligonucleotides for Spinal Muscular Atrophy Perturbed SMN2 Splicing in Patient Fibroblasts
    Wijaya, Yogik Onky Silvana
    Niba, Emma Tabe Eko
    Nishio, Hisahide
    Okamoto, Kentaro
    Awano, Hiroyuki
    Saito, Toshio
    Takeshima, Yasuhiro
    Shinohara, Masakazu
    GENES, 2022, 13 (04)
  • [47] Association between SMN2 methylation and disease severity in Chinese children with spinal muscular atrophy
    Cao, Yan-yan
    Qu, Yu-jin
    He, Sheng-xi
    Li, Yan
    Bai, Jin-li
    Jin, Yu-wei
    Wang, Hong
    Song, Fang
    JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2016, 17 (01): : 76 - 82
  • [48] Impact of missense mutations in survival motor neuron protein (SMN1) leading to Spinal Muscular Atrophy (SMA): A computational approach
    Sneha, P.
    Zenith, Tanzila U.
    Abu Habib, Ummay Salma
    Evangeline, Judith
    Kumar, D. Thirumal
    Doss, C. George Priya
    Siva, R.
    Zayed, Hatem
    METABOLIC BRAIN DISEASE, 2018, 33 (06) : 1823 - 1834
  • [49] Spinal Muscular Atrophy - Is Newborn Screening Too Late for Children with Two SMN2 Copies?
    Schwartz, Oliver
    Koelbel, Heike
    Blaschek, Astrid
    Glaeser, Dieter
    Burggraf, Siegfried
    Roeschinger, Wulf
    Schara, Ulrike
    Mueller-Felber, Wolfgang
    Vill, Katharina
    JOURNAL OF NEUROMUSCULAR DISEASES, 2022, 9 (03) : 389 - 396
  • [50] Pharmacokinetics, pharmacodynamics, and efficacy of a small-molecule SMN2 splicing modifier in mouse models of spinal muscular atrophy
    Zhao, Xin
    Feng, Zhihua
    Ling, Karen K. Y.
    Mollin, Anna
    Sheedy, Josephine
    Yeh, Shirley
    Petruska, Janet
    Narasimhan, Jana
    Dakka, Amal
    Welch, Ellen M.
    Karp, Gary
    Chen, Karen S.
    Metzger, Friedrich
    Ratni, Hasane
    Lotti, Francesco
    Tisdale, Sarah
    Naryshkin, Nikolai A.
    Pellizzoni, Livio
    Paushkin, Sergey
    Ko, Chien-Ping
    Weetall, Marla
    HUMAN MOLECULAR GENETICS, 2016, 25 (10) : 1885 - 1899